Showing all 2 results
Ethamsylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Oxidation-Resistant Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical survival of the highly reactive active ingredient.
Active Ingredient Strength Primary Clinical Function Ethamsylate USP/Ph.Eur. 250 mg The Prophylactic Surgical Standard: Base therapeutic unit utilized for pre-operative dosing to prevent excessive capillary oozing during delicate ENT (tonsillectomy) or dental procedures. Ethamsylate USP/Ph.Eur. 500 mg The Acute Gynecology Macrodose: Massive therapeutic payload utilized for the aggressive, immediate suppression of severe menorrhagia (heavy menstrual bleeding) and acute trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Metabisulfite / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Antioxidant / Film-Coating (Engineered specifically incorporating powerful antioxidants and a heavy moisture-barrier film to completely shield the API from atmospheric oxygen, preventing the tablet from degrading and turning black/pink on the shelf) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 5-to-10 day acute surgical and gynecological dispensing regimens).
Tranexamic Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Colorless Aqueous Solution in glass ampoules.
Active Ingredient Concentration Total Content & Format Tranexamic Acid BP/USP 100 mg / ml 500 mg in 5 ml Glass Ampoule Tranexamic Acid BP/USP 100 mg / ml 1000 mg (1 g) in 10 ml Glass Ampoule Excipients Water for Injection Preservative-Free Formulation *Pack Sizes: Tray of 5 or 10 Ampoules.
